These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28738140)

  • 41. Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Nji MAM; Solomon SD; Chen LY; Shah AM; Soliman EZ; Alam AB; Subramanya V; Alonso A
    Int J Cardiol; 2021 Sep; 339():47-53. PubMed ID: 34246724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.
    Gigliotti JN; Sidhu MS; Robert AM; Zipursky JS; Brown JR; Costa SP; Palac RT; Steckman DA; Malenka DJ; Kono AT; Greenberg ML
    Clin Cardiol; 2017 Oct; 40(10):861-864. PubMed ID: 28586090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.
    Fauchier L; Bisson A; Bodin A
    BMC Med; 2023 Feb; 21(1):54. PubMed ID: 36782248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study.
    Bosseau C; Donal E; Lund LH; Oger E; Hage C; Mulak G; Daubert JC; Linde C;
    Heart Vessels; 2017 Jun; 32(6):735-749. PubMed ID: 28028584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: The role of left atrial strain.
    Katbeh A; De Potter T; Geelen P; Di Gioia G; Kodeboina M; Balogh Z; Albano M; Vanderheyden M; Bartunek J; Barbato E; Van Camp G; Penicka M
    Int J Cardiol; 2021 Jan; 323():161-167. PubMed ID: 32882295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction.
    Franco J; Formiga F; Cepeda J; Llacer P; Arévalo-Lorido J; Cerqueiro J; González-Franco A; Epelde F; Manzano L; Montero Pérez-Barquero M;
    Med Clin (Barc); 2018 May; 150(10):376-382. PubMed ID: 28870424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkers.
    Dattani A; Brady EM; Kanagala P; Stoma S; Parke KS; Marsh AM; Singh A; Arnold JR; Moss AJ; Zhao L; Cvijic ME; Fronheiser M; Du S; Costet P; Schafer P; Carayannopoulos L; Chang CP; Gordon D; Ramirez-Valle F; Jerosch-Herold M; Nelson CP; Squire IB; Ng LL; Gulsin GS; McCann GP
    BMC Cardiovasc Disord; 2024 Feb; 24(1):94. PubMed ID: 38326736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fraction.
    Fan L; Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
    Intern Med J; 2022 Feb; 52(2):301-309. PubMed ID: 32744416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications.
    Naser JA; Lee E; Scott CG; Kennedy AM; Pellikka PA; Lin G; Pislaru SV; Borlaug BA
    Eur Heart J; 2023 Dec; 44(48):5049-5060. PubMed ID: 37639219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis.
    Kalantarian S; Ay H; Gollub RL; Lee H; Retzepi K; Mansour M; Ruskin JN
    Ann Intern Med; 2014 Nov; 161(9):650-8. PubMed ID: 25364886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
    Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.
    Gorter TM; van Melle JP; Rienstra M; Borlaug BA; Hummel YM; van Gelder IC; Hoendermis ES; Voors AA; van Veldhuisen DJ; Lam CSP
    J Card Fail; 2018 Mar; 24(3):177-185. PubMed ID: 29197548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis.
    Rattka M; Kühberger A; Pott A; Stephan T; Weinmann K; Baumhardt M; Aktolga D; Teumer Y; Bothner C; Scharnbeck D; Rottbauer W; Dahme T
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2357-2367. PubMed ID: 34379370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of AF in Heart Failure With Preserved Ejection Fraction: Incremental Value of Left Atrial Strain.
    Jasic-Szpak E; Marwick TH; Donal E; Przewlocka-Kosmala M; Huynh Q; Gozdzik A; Woznicka AK; Jankowska EA; Ponikowski P; Kosmala W
    JACC Cardiovasc Imaging; 2021 Jan; 14(1):131-144. PubMed ID: 33413883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara P; Patel N; Venkatesh S; Samman-Tahhan A; Hammadah M; Kelli HM; Soliman EZ
    Eur Heart J Cardiovasc Imaging; 2017 Jul; 18(7):725-729. PubMed ID: 28379310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between atrial fibrillation and heart failure with different ejection fraction categories and its influence on outcomes.
    Xu HX; Zhu YM; Hua Y; Huang YH; Lu Q
    Acta Cardiol; 2020 Sep; 75(5):423-432. PubMed ID: 31141463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.